That is why NUH will struggle to obtain authority in the hearing...

First 40 Last

Share
Profile

Follow
kickit2me

4,638 Posts.

1144

04/05/18

18:17

Post #: 32895247
Share

Originally posted by bruutz82 ↑

1) NUHs branding in the twitterverse is obviously not that great because you are a production stage stock with fairly low receipts in your last quarter. If it is so great perhaps your receipts should have been higher? NTI is a development stage stock so for us it is all about meeting our full study publication end point milestone and then FDA submission milestone.

2) Your comment about publications dont sell product further indicates to me that you don't understand the medical device market. Twitterverse is the last place that will help NTI obtain the authority in the autism field.

But hey, thats the difference between NTI and NUH right? NTI is in the medical device market and NUH is in the electronic consumerables market.

That is why NUH will struggle to obtain authority in the hearing aid market and also in the medical field of Auditory Processing Disorder.

NUHs attempt to indicate that it was going to lead in the APD field when all it does is amplify sound was embarrasing. It does not even resolve the underlying condition.

That is the obvious difference between NUH and NTI.

Expand

That is why NUH will struggle to obtain authority in the hearing aid market.

What about these three recent measures of authority?

Australian Government approves Nuheara as a registered device supplier under the Hearing Services Program (HSP):
http://www.aspecthuntley.com.au/doc...Jyb3JwYWdlcy9wZGZkZWxheWVkLmpzcA==&popup=true

Globally renowned research organisation, National Acoustic Laboratories (NAL), has clinically validated the validity and reliability of Nuheara’s proprietary hearing assessment technology, Ear ID™:
http://www.aspecthuntley.com.au/doc...Jyb3JwYWdlcy9wZGZkZWxheWVkLmpzcA==&popup=true

Nuheara continues Hearing Health Care channel expansion: (Connect Hearing are part of Sonova - look them up):
http://www.aspecthuntley.com.au/doc...Jyb3JwYWdlcy9wZGZkZWxheWVkLmpzcA==&popup=true

NTI Price at posting: 19.0¢ Sentiment: None Disclosure: Not Held
3 Upvote

0 Great analysis

Reply

Top Stories

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Chaos reigns markets – so let's take stock of where we're at ahead of December

First 40 Last

Add NTI (ASX) to my watchlist

(20min delay)
Last 7.0¢		Change 0.001(1.45%)		Mkt cap ! $64.55M

Open	High	Low	Value	Volume
7.1¢	7.1¢	7.0¢	$16.67K	237.0K

Buyers (Bids)

No.	Vol.	Price($)
3	75250	6.9¢

Sellers (Offers)

Price($)	Vol.	No.
7.0¢	23082	1

View Market Depth

No.	Vol.	Price($)
4	589299	0.070
1	36231	0.069
5	240000	0.068
2	255000	0.067
3	262000	0.066

Price($)	Vol.	No.
0.072	100000	1
0.074	40000	1
0.075	738582	2
0.076	90000	1
0.077	190000	3

Last trade - 14.13pm 28/11/2024 (20 minute delay)

NTI (ASX) Chart

That is why NUH will struggle to obtain authority in the hearing...

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Chaos reigns markets – so let's take stock of where we're at ahead of December

Buyers (Bids)

Sellers (Offers)